Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is S  [Clear All Filters]
1988
Hökfelt T, Foster G, Schultzberg M, Meister B, Schalling M, Goldstein M, Hemmings HC, Ouimet C, Greengard P.  1988.  DARPP-32 as a marker for D-1 dopaminoceptive cells in the rat brain: prenatal development and presence in glial elements (tanycytes) in the basal hypothalamus.. Adv Exp Med Biol. 235:65-82.
Foster GA, Schultzberg M, Kökfelt T, Goldstein M, Hemmings HC, Ouimet CC, Walaas SI, Greengard P.  1988.  Ontogeny of the dopamine and cyclic adenosine-3':5'-monophosphate-regulated phosphoprotein (DARPP-32) in the pre- and postnatal mouse central nervous system.. Int J Dev Neurosci. 6(4):367-86.
Savarese JJ, Thomas GB, Homesley H, Hill CS.  1988.  Rescue factor: a design for evaluating long-acting analgesics.. Clin Pharmacol Ther. 43(4):376-80.
Goldhill DR, Embree PB, Ali HH, Savarese JJ.  1988.  Reversal of pancuronium. Neuromuscular and cardiovascular effects of a mixture of neostigmine and glycopyrronium.. Anaesthesia. 43(6):443-6.
1987
Khojasteh A, Evans W, Reynolds RD, Thomas G, Savarese JJ.  1987.  Controlled-release oral morphine sulfate in the treatment of cancer pain with pharmacokinetic correlation.. J Clin Oncol. 5(6):956-61.
Foster GA, Schultzberg M, Hökfelt T, Goldstein M, Hemmings HC, Ouimet CC, Walaas SI, Greengard P.  1987.  Development of a dopamine- and cyclic adenosine 3':5'-monophosphate-regulated phosphoprotein (DARPP-32) in the prenatal rat central nervous system, and its relationship to the arrival of presumptive dopaminergic innervation.. J Neurosci. 7(7):1994-2018.
Meed SD, Kleinman PM, Kantor TG, Blum RH, Savarese JJ.  1987.  Management of cancer pain with oral controlled-release morphine sulfate.. J Clin Pharmacol. 27(2):155-61.
1986
Scott RP, Savarese JJ, Basta SJ, Embree P, Ali HH, Sunder N, Hoaglin DC.  1986.  Clinical pharmacology of atracurium given in high dose.. Br J Anaesth. 58(8):834-8.
Scott RP, Savarese JJ, Basta SJ, Embree P, Ali HH, Sunder N, Hoaglin DC.  1986.  Clinical pharmacology of atracurium given in high dose.. Br J Anaesth. 58(8):834-8.
Scott RP, Savarese JJ, Basta SJ, Embree P, Ali HH, Sunder N, Hoaglin DC.  1986.  Clinical pharmacology of atracurium given in high dose.. Br J Anaesth. 58(8):834-8.
Savarese JJ.  1986.  Clinical relaxation: current controversy.. Can Anaesth Soc J. 33(3 Pt 2):S1-4.
Stone RA, Laties AM, Hemmings HC, Ouimet CC, Greengard P.  1986.  DARPP-32 in the ciliary epithelium of the eye: a neurotransmitter-regulated phosphoprotein of brain localizes to secretory cells.. J Histochem Cytochem. 34(11):1465-8.
deBros FM, Lai A, Scott R, deBros J, Batson AG, Goudsouzian N, Ali HH, Cosimi AB, Savarese JJ.  1986.  Pharmacokinetics and pharmacodynamics of atracurium during isoflurane anesthesia in normal and anephric patients.. Anesth Analg. 65(7):743-6.
deBros FM, Lai A, Scott R, deBros J, Batson AG, Goudsouzian N, Ali HH, Cosimi AB, Savarese JJ.  1986.  Pharmacokinetics and pharmacodynamics of atracurium during isoflurane anesthesia in normal and anephric patients.. Anesth Analg. 65(7):743-6.
Savarese JJ, Goldenheim PD, Thomas GB, Kaiko RF.  1986.  Steady-state pharmacokinetics of controlled release oral morphine sulphate in healthy subjects.. Clin Pharmacokinet. 11(6):505-10.
1985
Scott RP, Savarese JJ, Basta SJ, Sunder N, Ali HH, Gargarian M, Gionfriddo M, Batson AG.  1985.  Atracurium: clinical strategies for preventing histamine release and attenuating the haemodynamic response.. Br J Anaesth. 57(6):550-3.
Scott RP, Savarese JJ, Basta SJ, Sunder N, Ali HH, Gargarian M, Gionfriddo M, Batson AG.  1985.  Atracurium: clinical strategies for preventing histamine release and attenuating the haemodynamic response.. Br J Anaesth. 57(6):550-3.
Scott RP, Savarese JJ, Basta SJ, Sunder N, Ali HH, Gargarian M, Gionfriddo M, Batson AG.  1985.  Atracurium: clinical strategies for preventing histamine release and attenuating the haemodynamic response.. Br J Anaesth. 57(6):550-3.
Savarese JJ, Lowenstein E.  1985.  The name of the game: no anesthesia by cookbook.. Anesthesiology. 62(6):703-5.
1983
Savarese JJ, Ali HH, Basta SJ, Sunder N, Moss J, Gionfriddo MA, Lineberry CG, Wastila WB, el-Sayad HA, Montague D et al..  1983.  The clinical pharmacology of BW A444U. A nondepolarizing ester relaxant of intermediate duration.. Anesthesiology. 58(4):333-41.
Savarese JJ, Ali HH, Basta SJ, Sunder N, Moss J, Gionfriddo MA, Lineberry CG, Wastila WB, el-Sayad HA, Montague D et al..  1983.  The clinical pharmacology of BW A444U. A nondepolarizing ester relaxant of intermediate duration.. Anesthesiology. 58(4):333-41.
Ali HH, Savarese JJ, Basta SJ, Sunder N, Gionfriddo M.  1983.  Evaluation of cumulative properties of three new nondepolarizing neuromuscular blocking drugs BW A444U, atracurium and vecuronium.. Br J Anaesth. 55 Suppl 1:107S-111S.
Ali HH, Savarese JJ, Basta SJ, Sunder N, Gionfriddo M.  1983.  Evaluation of cumulative properties of three new nondepolarizing neuromuscular blocking drugs BW A444U, atracurium and vecuronium.. Br J Anaesth. 55 Suppl 1:107S-111S.
Basta SJ, Savarese JJ, Ali HH, Moss J, Gionfriddo M.  1983.  Histamine-releasing potencies of atracurium, dimethyl tubocurarine and tubocurarine.. Br J Anaesth. 55 Suppl 1:105S-106S.
1982
Basta SJ, Ali HH, Savarese JJ, Sunder N, Gionfriddo M, Cloutier G, Lineberry C, Cato AE.  1982.  Clinical pharmacology of atracurium besylate (BW 33A): a new non-depolarizing muscle relaxant.. Anesth Analg. 61(9):723-9.